161 related articles for article (PubMed ID: 17720497)
1. Myasthenia gravis in South Africans: racial differences in clinical manifestations.
Heckmann JM; Owen EP; Little F
Neuromuscul Disord; 2007 Dec; 17(11-12):929-34. PubMed ID: 17720497
[TBL] [Abstract][Full Text] [Related]
2. The characteristics of juvenile myasthenia gravis among South Africans.
Heckmann JM; Hansen P; Van Toorn R; Lubbe E; Janse van Rensburg E; Wilmshurst JM
S Afr Med J; 2012 May; 102(6):532-6. PubMed ID: 22668957
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in myasthenia gravis in Alabama.
Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
Muscle Nerve; 2009 Mar; 39(3):328-32. PubMed ID: 19127534
[TBL] [Abstract][Full Text] [Related]
4. Acquired myasthenia gravis in childhood.
Evoli A
Curr Opin Neurol; 2010 Oct; 23(5):536-40. PubMed ID: 20581680
[TBL] [Abstract][Full Text] [Related]
5. [Seronegative myasthenia gravis].
Gajdos P
Rev Neurol (Paris); 2004 Feb; 160(2):159-62. PubMed ID: 15034472
[TBL] [Abstract][Full Text] [Related]
6. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis: a study from India.
Singhal BS; Bhatia NS; Umesh T; Menon S
Neurol India; 2008; 56(3):352-5. PubMed ID: 18974563
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting outcome in ocular myasthenia gravis.
Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
[TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
[TBL] [Abstract][Full Text] [Related]
10. Paediatric myasthenia gravis: Prognostic factors for drug free remission.
Vecchio D; Ramdas S; Munot P; Pitt M; Beeson D; Knight R; Rodríguez Cruz P; Vincent A; Jayawant S; DeVile C; Buckley C; Hilton-Jones D; Robb S; Palace J
Neuromuscul Disord; 2020 Feb; 30(2):120-127. PubMed ID: 32001147
[TBL] [Abstract][Full Text] [Related]
11. MuSK-antibody-positive myasthenia gravis in a South Asian population.
Chang T; Gunaratne P; Gamage R; Riffsy MT; Vincent A
J Neurol Sci; 2009 Sep; 284(1-2):33-5. PubMed ID: 19394052
[TBL] [Abstract][Full Text] [Related]
12. Lifetime course of myasthenia gravis.
Grob D; Brunner N; Namba T; Pagala M
Muscle Nerve; 2008 Feb; 37(2):141-9. PubMed ID: 18059039
[TBL] [Abstract][Full Text] [Related]
13. Pattern of ocular involvement in myasthenia gravis with MuSK antibodies.
Evoli A; Alboini PE; Iorio R; Damato V; Bartoccioni E
J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):761-763. PubMed ID: 28601810
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R;
Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of patients with Myasthenia gravis from the Henan province, China.
Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
[TBL] [Abstract][Full Text] [Related]
16. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
Yan C; Zhao R; Song J; Feng X; Xi J; Luo S; Zhong H; Zhou S; Li W; Zhao C
J Neuroimmunol; 2020 Dec; 349():577403. PubMed ID: 32992216
[TBL] [Abstract][Full Text] [Related]
17. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.
Huda S; Woodhall MR; Vincent A; Heckmann JM
Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical aspects of immigrants with myasthenia gravis in northern Europe.
Boldingh MI; Maniaol A; Brunborg C; Dekker L; Lipka A; Niks EH; Verschuuren J; Tallaksen C
Muscle Nerve; 2017 Jun; 55(6):819-827. PubMed ID: 27641227
[TBL] [Abstract][Full Text] [Related]
20. Thymoma-associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma.
De Rosa A; Fornili M; Maestri Tassoni M; Guida M; Baglietto L; Petrucci L; Chella A; Melfi F; Lucchi M; Ricciardi R
Thorac Cancer; 2021 Jan; 12(1):106-113. PubMed ID: 33142021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
